Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Afolabi J Owoloye"'
Autor:
Afolabi J Owoloye, Funmilayo C Ligali, Ojochenemi A Enejoh, Adesola Z Musa, Oluwagbemiga Aina, Emmanuel T Idowu, Kolapo M Oyebola
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0268269 (2022)
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New drugs are required for ancillary support of existing malaria control efforts. Plasmodium falciparum requires host glucose for survival and proliferation. On th
Externí odkaz:
https://doaj.org/article/0b4a51b4246a487abf867e351f52e684
Autor:
Kolapo M. Oyebola, Funmilayo C. Ligali, Afolabi J. Owoloye, Oluwagbemiga O. Aina, Yetunde M. Alo, Blessing Erinwusi, Michael J. Olufemi, Babatunde L. Salako
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Background The burden of malaria persists in sub-Saharan Africa and the emergence of artemisinin resistance has introduced complexity to control efforts. Monitoring the efficacy of artemisinin-based treatment for malaria is crucial to addres
Externí odkaz:
https://doaj.org/article/a3b7a6b09d1d401fa9dca822ba9e5481
Autor:
Afolabi J. Owoloye, Funmilayo C. Ligali, Ojochenemi A. Enejoh, Adesola Z. Musa, Oluwagbemiga Aina, Emmanuel T. Idowu, Kolapo M. Oyebola
Malaria chemotherapy has been plagued by parasite resistance. Novel drugs must be continually explored for malaria treatment. Plasmodium falciparum requires host glucose for survival and proliferation. Protein involved in hexose permeation, P. falcip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2593c6a733033a1e6c7cab51082037a
https://doi.org/10.1101/2022.04.27.489756
https://doi.org/10.1101/2022.04.27.489756
